Ninety-Day Readmission and Morbidity Following Liver Transplantation for MASLD.

Clin Transplant · 2026 · PMC12873555 · PMID 41640281

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

a strong trendp = 0.05actually significant

When comparing 90‐day outcomes, MASLD LT recipients with liver cancer experienced a decreased length of stay ( p < 0.05) and a strong trend towards reduced 90‐day morbidity and mortality ( p = 0.05).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.